The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab or pembrolizumab: Which is the better subsequent treatment in patients with advanced urothelial carcinoma who did not show progression after 4 cycles of first line chemotherapy?
 
Ikko Tomisaki
No Relationships to Disclose
 
Mirii Harada
No Relationships to Disclose
 
Akinori Minato
No Relationships to Disclose
 
Katsuyoshi Higashijima
No Relationships to Disclose
 
Tomohisa Takaba
No Relationships to Disclose
 
Yujiro Nagata
No Relationships to Disclose
 
Kenichi Harada
No Relationships to Disclose
 
Naohiro Fujimoto
No Relationships to Disclose